А. К. Голенков
Moscow Regional Scientific Research Clinical Institute. MF Vladimirsky · 69 works · 293 citations · h-index 5
Top works
- Phase I to II Multicenter Study of Oblimersen Sodium, a Bcl-2 Antisense Oligonucleotide, in Patients With Advanced Chronic Lymphocytic Leukemia
- Phase 3 Randomized Trial of Fludarabine/Cyclophosphamide Chemotherapy with or without Oblimersen Sodium (Bcl-2 Antisense; Genasense; G3139) for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL).
- Clinical Recommendations for the Diagnosis and Treatment of Chronic Myeloid Leukemia
- Клеточная агрегация повышает лекарственную устойчивость клеток острого миелоидного лейкоза
- Chronic Myeloid Leukemia Patient Registry in the Russian Federation: From Observational Studies to the Efficacy Evaluation in Clinical Practice
- Efficacy of lenalidomide, bortezomib, and prednisolone in patients with relapsed or refractory multiple myeloma
- The inhibition of NF-kB activation decreases the resistance of acute myeloid leukemia cells to TRAIL-induced apoptosis in multicellular aggregates
- THE EFFECT OF MULTIDRUG RESISTANCE GENE EXPRESSION ON THE CLINICAL COURSE OF MULTIPLE MYELOMA
- [Gene expression of vascular endothelial growth factors and their receptors in different variants of the course of multiple myeloma].
- Cell aggregation increases drug resistance of acute myeloid leukemia cells
- INCREASE OF DRUG RESISTANCE OF ACUTE MYELOID LEUKEMIA CELLS IN MULTICELLULAR AGGREGATES IN VITRO
- Treatment efficacy of chronic myeloid leukemia with imatinib in clinical practice
- Expression of the apoptosis-releated genes in patients with newly diagnosed chronic lymphocytic leukemia in clinical data context
- Effect of human regulatory myelopeptides on production of leukocyte migration inhibition factor
- Imexon (AOP 99.0001) for Treatment of Relapsed or Refractory Multiple Myeloma: A Phase I/II Study
- Interleukin-1 and interleukin-6 production in peripheral blood and bone marrow mononuclear cell culture in multiple myeloma
- Таргетное лечение нилотинибом резистентного хронического миелолейкоза
- Эффективность лечения больных хроническим миелолейкозом иматинибом в широкой клинической практике
- Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine
- Клиническое значение линейно-адгезивного фенотипа опухолевых клеток при хроническом лимфолейкозе